JP2024535128A5 - - Google Patents

Info

Publication number
JP2024535128A5
JP2024535128A5 JP2024539911A JP2024539911A JP2024535128A5 JP 2024535128 A5 JP2024535128 A5 JP 2024535128A5 JP 2024539911 A JP2024539911 A JP 2024539911A JP 2024539911 A JP2024539911 A JP 2024539911A JP 2024535128 A5 JP2024535128 A5 JP 2024535128A5
Authority
JP
Japan
Prior art keywords
group
ring
alkyl
independently selected
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024539911A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024535128A (ja
Filing date
Publication date
Priority claimed from GBGB2113079.4A external-priority patent/GB202113079D0/en
Application filed filed Critical
Publication of JP2024535128A publication Critical patent/JP2024535128A/ja
Publication of JP2024535128A5 publication Critical patent/JP2024535128A5/ja
Pending legal-status Critical Current

Links

JP2024539911A 2021-09-14 2022-09-14 新規治療 Pending JP2024535128A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2113079.4A GB202113079D0 (en) 2021-09-14 2021-09-14 New therapy
GB2113079.4 2021-09-14
PCT/GB2022/052323 WO2023041905A1 (en) 2021-09-14 2022-09-14 Aminopyridines as activators of pi3 kinase

Publications (2)

Publication Number Publication Date
JP2024535128A JP2024535128A (ja) 2024-09-26
JP2024535128A5 true JP2024535128A5 (enExample) 2025-08-28

Family

ID=78149414

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024539911A Pending JP2024535128A (ja) 2021-09-14 2022-09-14 新規治療

Country Status (6)

Country Link
US (1) US20250263404A1 (enExample)
EP (1) EP4402127A1 (enExample)
JP (1) JP2024535128A (enExample)
CA (1) CA3232412A1 (enExample)
GB (1) GB202113079D0 (enExample)
WO (1) WO2023041905A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025045915A1 (en) 2023-08-29 2025-03-06 Institut National de la Santé et de la Recherche Médicale Methods for inducing muscle hypertrophy
CN119732953A (zh) * 2024-12-25 2025-04-01 中国医学科学院北京协和医院 一种PI3Kα激活剂用于治疗肌萎缩侧索硬化症的用途
CN120204225A (zh) * 2025-05-28 2025-06-27 中国医学科学院北京协和医院 Pi3k激活剂在治疗阿尔茨海默症中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2727909A1 (en) * 2007-03-16 2014-05-07 The Scripps Research Institute Inhibitors of focal adhesion kinase
CN110691782A (zh) * 2016-12-01 2020-01-14 艾普托斯生物科学公司 作为brd4和jak2双重抑制剂的稠合的嘧啶化合物及其使用方法

Similar Documents

Publication Publication Date Title
JP2024535128A5 (enExample)
JP2009536620A5 (enExample)
JP2011527686A5 (enExample)
JP2021535112A5 (enExample)
JP2022510313A5 (enExample)
JP2017507122A5 (enExample)
JP2021512059A5 (enExample)
BR112021005903A2 (pt) inibidores de vap-1
JP2024524766A5 (enExample)
JP2005535586A5 (enExample)
JP2007505877A5 (enExample)
JP2022519239A5 (enExample)
RU2013126947A (ru) Соединения, пригодные для лечения спида
JP2005526028A5 (enExample)
JP2021535213A5 (enExample)
JP2021518400A5 (enExample)
JP2020122016A5 (enExample)
JP2022525069A5 (enExample)
JP2009538910A5 (enExample)
JP2024516633A5 (enExample)
JP2006501201A5 (enExample)
JP2023522177A5 (enExample)
JP2021530525A5 (enExample)
JP2021500332A5 (enExample)
JP2018503661A5 (enExample)